Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 2/20 | 0.51 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31509586 | 0.85 | HDAC1 (0.48) | MAOBCA12CA1CA2CA9 | |
| SCHEMBL31509592 | 0.85 | MAOB (0.54) | MAOBPLA2G4BCA12CA1CA2 | |
| SCHEMBL26185842 | 0.84 | MAOB (0.58) | MAOBPLA2G4BCA12CA1CA2 | |
| SCHEMBL13456452 | 0.80 | CA2 (0.49) | CA1CA2GAAMAPTALDH1A1 | |
| SCHEMBL31509543 | 0.79 | RAB9A (0.49) | GAAMAPTALDH1A1 | |
| SCHEMBL5723865 | 0.78 | ALDH1A1 (0.65) | GAAMAPTALDH1A1 | |
| SCHEMBL16817686 | 0.76 | MAPT (0.57) | GAAMAPTALDH1A1 | |
| SCHEMBL20467732 | 0.75 | HTR2A (0.54) | GAAMAPTALDH1A1 | |
| SCHEMBL7068808 | 0.75 | BCL9 (0.56) | GAAMAPTALDH1A1 | |
| SCHEMBL21792430 | 0.75 | MMP1 (0.45) | MAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025085489-A1 | GSPT1-DEGRADING COMPOUNDS, ANTI-CD33 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES AND USES THEREOF | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-04-24 | — | — | WO | disclosed |